The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
The SPRINT Research Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1511939 · Cited by 6,325
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Sontrop, J. M., Dixon, S. N., Garg, A. X., Buendia-Jimenez, I., Dohein, O., Huang, S.-H. S., & Clark, W. F. (2013) · American Journal of Nephrology · doi:10.1159/000350377 · Cited by 5,871
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Telmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,766
Mann, J. F. E., Gerstein, H. C., Pogue, J., Bosch, J., Yusuf, S., & for the HOPE Investigators (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00007 · Cited by 1,372
Williamson, J. D., Supiano, M. A., Applegate, W. B., Berlowitz, D. R., Campbell, R. C., Chertow, G. M., Fine, L. J., Haley, W. E., Hawfield, A. T., Ix, J. H., et al. (2016) · JAMA · doi:10.1001/jama.2016.7050 · Cited by 1,261
Jafar, T. H., Stark, P. C., Schmid, C. H., Landa, M., Maschio, G., de Jong, P. E., de Zeeuw, D., Shahinfar, S., Toto, R., Levey, A. S., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-4-200308190-00006 · Cited by 1,157
Vascular Health and Risk Management
(2020) · Vascular Health and Risk Management · doi:10.2147/vhrm · Cited by 700
Muntner, P., Anderson, A., Charleston, J., Chen, Z., Ford, V., Makos, G., O'Connor, A., Perumal, K., Rahman, M., Steigerwalt, S., et al. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.09.014 · Cited by 423
Hallan, S. I., Dahl, K., Oien, C. M., Grootendorst, D. C., Aasberg, A., Holmen, J., & Dekker, F. W. (2006) · BMJ · doi:10.1136/bmj.39001.657755.be · Cited by 330
The epidemiology of chronic kidney disease
Atkins, R. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09403.x · Cited by 320
Blood Pressure Lowering Treatment Trialists' Collaboration (2013) · BMJ · doi:10.1136/bmj.f5680 · Cited by 263
Philipp, T., Smith, T. R., Glazer, R., Wernsing, M., Yen, J., Jin, J., Schneider, H., & Pospiech, R. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.03.018 · Cited by 262
Clase, C. M., Garg, A. X., & Kiberd, B. A. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000013291.78621.26 · Cited by 223
Effect of Telmisartan on Renal Outcomes: A Randomized Trial
Mann, J. F. E., Schmieder, R. E., Dyal, L., McQueen, M. J., Schumacher, H., Pogue, J., Wang, X., Probstfield, J. L., Avezum, A., Cardona-Munoz, E., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-1-200907070-00122 · Cited by 196
Ford, E. S. (2011) · Circulation · doi:10.1161/circulationaha.110.005645 · Cited by 183
Prevalence of Apparent Treatment-Resistant Hypertension among Individuals with CKD
Tanner, R. M., Calhoun, D. A., Bell, E. K., Bowling, C. B., Gutiérrez, O. M., Irvin, M. R., Lackland, D. T., Oparil, S., Warnock, D., & Muntner, P. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00550113 · Cited by 168
Allemann, Y., Fraile, B., Lambert, M., Barbier, M. C., Ferber, P. C., & Izzo, J. L. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07516.x · Cited by 113
Haller, H. G., Viberti, G. C., Mimran, A., Remuzzi, G., Rabelink, T. J., Ritz, E., Rump, L. C., Ruilope, L. M., Katayama, S., Ito, S., et al. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000202820.56201.e6 · Cited by 106
Böhm, M., Thoenes, M., Danchin, N., Bramlage, P., Puerta, P. L., & Volpe, M. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282ef1c5f · Cited by 99
A random comparison of fosinopril and nifedipine GITS in patients with primary renal disease
Marín, R., Ruilope, L. M., Aljama, P., Aranda, P. J., Segura, J., & Dı́ez, J. (2001) · Journal of Hypertension · doi:10.1097/00004872-200110000-00023 · Cited by 92
Age and Outcomes Associated with BP in Patients with Incident CKD
Kovesdy, C. P., Alrifai, A. Z. A., Gosmanova, E. O., Lü, J., Canada, R. B., Wall, B. M., Hung, A. M., Molnar, M. Z., & Kalantar‐Zadeh, K. (2016) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08660815 · Cited by 92
Impact of fluid intake in the prevention of urinary system diseases: a brief review
Lotan, Y., Daudon, M., Bruyère, F., Talaska, G., Strippoli, G., Johnson, R. J., & Tack, I. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328360a268 · Cited by 72
Systolic BP and Mortality in Older Adults with CKD
Weiss, J. W., Peters, D., Yang, X., Petrik, A. F., Smith, D. H., Johnson, E. S., Thorp, M. L., Morris, C. D., & O’Hare, A. M. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11391114 · Cited by 69
Slowing progression of chronic kidney disease
Drawz, P. E., & Rosenberg, M. E. (2013) · Kidney International Supplements · doi:10.1038/kisup.2013.80 · Cited by 65
Mancia, G., Korlipara, K., van Rossum, P., Villa, G., & Silvert, B. (2002) · Blood Pressure Monitoring · doi:10.1097/00126097-200204000-00008 · Cited by 59
Cardio-renal syndromes: a systematic approach for consensus definition and classification
Ronco, C., & Ronco, F. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9224-0 · Cited by 56
Saruta, T., Hayashi, K., Ogihara, T., Nakao, K., Fukui, T., Fukiyama, K., & for the CASE-J Study Group (2009) · Hypertension Research · doi:10.1038/hr.2009.44 · Cited by 55
Kanno, A., Metoki, H., Kikuya, M., Terawaki, H., Hara, A., Hashimoto, T., Asayama, K., Inoue, R., Shishido, Y., Nakayama, M., et al. (2010) · Hypertension Research · doi:10.1038/hr.2010.139 · Cited by 43
ACE Inhibitors and Appearance of Renal Events in Hypertensive Nephrosclerosis
Segura, J., Campo, C., Rodicio, J. L., & Ruilope, L. M. (2001) · Hypertension · doi:10.1161/hy09t1.096184 · Cited by 40
Sica, D. A. (2003) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2003.01924.x · Cited by 35
Warmoth, L. A., Regalado, M., Wesson, D. E., Simoni, J. M., & Harrist, R. B. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200509000-00003 · Cited by 29
Bobrie, G. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.06.026 · Cited by 22
Borghi, C., & Cicero, A. F. G. (2012) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/11632100-000000000-00000 · Cited by 21
Petrella, R. J., & Michailidis, P. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.08.008 · Cited by 20
Ekman, M., Bienfait-Beuzon, C., & Jackson, J. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.76 · Cited by 19
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan
Maniadakis, N., & Gialama, F. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s50831 · Cited by 19
Maniadakis, N., Ekman, M., Fragoulakis, V., Papagiannopoulou, V., & Yfantopoulos, J. (2010) · The European Journal of Health Economics · doi:10.1007/s10198-010-0243-5 · Cited by 17
Bobrie, G. (2012) · Clinical Therapeutics · doi:10.1016/j.clinthera.2012.07.001 · Cited by 16
Ofili, E., Oparil, S., Giles, T. D., Pitt, B., Purkayastha, D., Hilkert, R. J., Samuel, R., & Sowers, J. R. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.02.007 · Cited by 10
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Levey, A. S., Eckardt, K.-U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Zeeuw, D. D. E., Hostetter, T. H., Lameire, N., & Eknoyan, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00365.x · Cited by 3,946
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705
Authors/Task Force Members:, Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehm236 · Cited by 2,384
Inker, L. A., Astor, B. C., Fox, C. H., Isakova, T., Lash, J. P., Peralta, C. A., Kurella Tamura, M., & Feldman, H. I. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.01.416 · Cited by 1,779
Metadata
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2004-05
- Volume
- 43
- Pages
- 11-13
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2297164013
- Cited by
- 1,245
- References
- 49
- FWCI
- 47.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.